5,5-Dimethyloctan-1-amine

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: 5,5-Dimethyloctan-1-amine
• 英文别名: 5,5-dimethyloctan-1-amine
• 化学式: C₁₀H₂₃N
• 分子量: 157.3
• InChiKey: LMIOKPGNPJUDJL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  11
• 可旋转键数：
  6
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  26
• 氢给体数：
  1
• 氢受体数：
  1

文献信息

• Antibacterial compounds, compositions thereof, and methods using same
  申请人：The Rockefeller University

  公开号：US11339184B2

  公开（公告）日：2022-05-24

  The present disclosure includes novel compounds useful as antimicrobial agents. The present disclosure further includes methods useful. The present disclosure further includes compositions and methods for treating or preventing a bacterial infection. The present disclosure further includes compositions and methods useful for preventing or reducing the growth or proliferation of microorganisms.

  本公开包括可用作抗菌剂的新型化合物。本公开还包括有用的方法。本公开进一步包括用于治疗或预防细菌感染的组合物和方法。本公开内容还包括用于防止或减少微生物生长或增殖的组合物和方法。
• ANTIBACTERIAL COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS USING SAME
  申请人：The Rockefeller University

  公开号：US20210024562A1

  公开（公告）日：2021-01-28

  The present disclosure includes novel compounds useful as antimicrobial agents. The present disclosure further includes methods useful. The present disclosure further includes compositions and methods for treating or preventing a bacterial infection. The present disclosure further includes compositions and methods useful for preventing or reducing the growth or proliferation of microorganisms.
• PEPTIDE NUCLEIC ACID (PNA) MONOMERS WITH AN ORTHOGONALLY PROTECTED ESTER MOIETY AND NOVEL INTERMEDIATES AND METHODS RELATED THERETO
  申请人：VERA THERAPEUTICS, INC.

  公开号：US20210171437A1

  公开（公告）日：2021-06-10

  The present disclosure pertains to peptide nucleic acid (PNA) monomers and oligomers, as well as methods and compositions useful for the preparation of PNA monomer precursors (e.g. PNA Monomer Esters, Backbone Esters and Backbone Ester Acid Salts, as described below) that can be used to prepare PNA monomers wherein said PNA monomers can be used to prepare said PNA oligomers. In some embodiments, the disclosure features sulfonic acid salts of Backbone Ester compounds, which sulfonic acid salts generally tend to be crystalline and can be obtained in reasonably good yield, often without requiring any chromatographic purification of the reaction product of the Backbone Ester synthesis reaction. This disclosure also pertains to novel methods for the synthesis of said Backbone Ester compounds and novel methods for the formation of the related sulfonic acid salts. Exemplary ester groups include, but are not limited to, 2,2,2-trichloroethy-(TCE), 2,2,2-tribromoethyl-(TBE), 2-iodoethyl-groups (2-IE) and 2-bromoethyl-(2-BrE) as the ester group. These particular ester groups can be removed under conditions where both Boc and Fmoc protected amine groups are stable.